Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996–2009

To describe demographic characteristics, clinical features and outcome of Jordanian patients with idiopathic inflammatory myopathies (IIM), a retrospective chart review of all patients diagnosed with IIM at Jordan University Hospital between 1996 and 2009 was carried out. Thirty patients with IIM were identified. Female to male ratio was 1.7:1, with mean age at diagnosis 34.3 ± 9.2 (10–72) years with bimodal presentation at 21 and 49 years and a mean follow-up of 6.5 ± 5.7 years. Eleven patients had polymyositis (PM); 19 patients had dermatomyositis (DM); 1 patient had DM with malignancy; 2 patients had juvenile DM; and 2 patients had DM/PM with other rheumatologic diseases. Raynaud's phenomenon was present in 26% of patients, dysphagia in 40%, fever in 16%, arthralgia/arthritis in 26%, and dyspnea was present in 26% patients. Positive muscle biopsy and EMG were present in 81% and 92% of patients, respectively. Elevated serum creatinine kinase (CK), AST/ALT and LDH were found in 90%, 72%, and 88% of patients at presentation, respectively. Interstitial fibrosis identified on high-resolution computed tomography (HRCT) was found in 7/14 (50%) patients. Restrictive lung disease was present in 16/21 (76%), low diffusion capacity of lung of carbon monoxide (DLCO) in 10/17 (59%) and pulmonary hypertension in only 3/19 (16%) patients tested. Arab Jordanian patients with IIM showed very low prevalence of malignancy, lower mean age than previous reports, and similar other clinical, laboratory and serologic markers, and survival rate to previous reports. Of interest, we found that extra-muscular manifestations were mainly associated with dermatomyositis.

[1]  G. Borgulya,et al.  Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical Features: A Longitudinal Study of 162 Cases , 2004, Medicine.

[2]  I. Lundberg,et al.  Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool. , 2001, The Journal of rheumatology.

[3]  Yong-Beom Park,et al.  Malignancies in Korean Patients with Inflammatory Myopathy , 2006, Yonsei medical journal.

[4]  I. Uthman,et al.  Distinctive features of idiopathic inflammatory myopathies in French Canadians. , 1996, Seminars in arthritis and rheumatism.

[5]  D. Brewster,et al.  Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study , 2001, British Journal of Cancer.

[6]  J. Benbassat,et al.  Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. , 1985, Arthritis and rheumatism.

[7]  A. Seow,et al.  Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. , 1993, Annals of the rheumatic diseases.

[8]  L. Carmona,et al.  Survival, mortality and causes of death in inflammatory myopathies , 2006, Autoimmunity.

[9]  E. Hachulla,et al.  Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. , 2001, The Journal of rheumatology.

[10]  D. Hilton‐Jones,et al.  Risk of cancer in dermatomyositis or polymyositis. , 1992, The New England journal of medicine.

[11]  S. Luo,et al.  Interstitial lung disease in polymyositis and dermatomyositis , 2009, Clinical Rheumatology.

[12]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[13]  M. Ehrenfeld,et al.  High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. , 1998, Seminars in arthritis and rheumatism.

[14]  M. Fritzler,et al.  Clinical and serologic features of patients with polymyositis or dermatomyositis. , 1985, Canadian Medical Association journal.

[15]  P. Szodoray,et al.  Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. , 2008, The Journal of rheumatology.

[16]  M. Dalakas.  Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.

[17]  B. Wallaert,et al.  Pulmonary involvement in polymyositis and in dermatomyositis. , 1998, The Journal of rheumatology.

[18]  B. Hellmich,et al.  Interstitial lung disease in polymyositis and dermatomyositis , 2005, Current rheumatology reports.

[19]  L. Gergely,et al.  Cancer‐Associated Myositis: Clinical Features and Prognostic Signs , 2005, Annals of the New York Academy of Sciences.

[20]  T. McLoud,et al.  Normal chest roentgenograms in chronic diffuse infiltrative lung disease. , 1978, The New England journal of medicine.

[21]  G. Hughes,et al.  Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment. , 1990, Seminars in arthritis and rheumatism.

[22]  R. Porkodi,et al.  Clinical spectrum of inflammatory myositis in South India--a ten year study. , 2002, The Journal of the Association of Physicians of India.

[23]  M. Hochberg,et al.  Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. , 1986, Seminars in arthritis and rheumatism.

[24]  Wei Zhang,et al.  Dermatomyositis and malignancy: a retrospective study of 115 cases. , 2009, European review for medical and pharmacological sciences.

[25]  D. Chung,et al.  Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. , 2005, Rheumatology.

[26]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[27]  P. Hudgson.  Polymyositis and dermatomyositis in adults. , 1984, Clinics in rheumatic diseases.

[28]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[29]  L. Jorfeldt,et al.  Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. , 2008, Arthritis and rheumatism.

[30]  N. Boyd,et al.  The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. , 1985, Archives of internal medicine.

[31]  W. J. Martin,et al.  Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. , 1987, Annals of the rheumatic diseases.

[32]  J. Berthelot,et al.  Long-term prognosis of 69 patients with dermatomyositis or polymyositis. , 1996, Clinical and experimental rheumatology.

[33]  G. Ríos.  Retrospective Review of the Clinical Manifestations and Outcomes in Puerto Ricans with Idiopathic Inflammatory Myopathies , 2005, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[34]  J. O'donnell,et al.  Adult‐onset inflammatory myopathy: North Canterbury experience 1989–2001 , 2005, Internal medicine journal.

[35]  David T Felson,et al.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study , 2001, The Lancet.

[36]  H. S. Davis,et al.  A Controlled Study , 1966 .

[37]  C. Pearson,et al.  A COMPUTER‐ASSISTED ANALYSIS OF 153 PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS , 1977, Medicine.

[38]  G. Giles,et al.  Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study , 2001, Annals of Internal Medicine.

[39]  D. Isenberg,et al.  Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. , 2002, Rheumatology.

[40]  I. Harrabi,et al.  [Polymyositis and dermatomyositis in adults. Tunisian multicentre study]. , 2008, La Revue de medecine interne.

[41]  E. Pukkala,et al.  Elevated cancer incidence in patients with dermatomyositis: a population based study. , 1995, The Journal of rheumatology.

[42]  J. Biederer,et al.  Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. , 2003, Seminars in arthritis and rheumatism.

[43]  T. Tosteson,et al.  Malignancy Is Associated with Dermatomyositis But Not Polymyositis in Northern New England, USA , 2009, The Journal of Rheumatology.

[44]  A. Al-Dalaan,et al.  Pattern of adult onset of polymyositis and dermatomyositis and association with malignancy. , 1993, Annals of Saudi medicine.